Signatera Assessment in Early-Stage Endometrial Cancer
← catalyst calendarNCT07339384 · readout ≤ 2,994 d
Sponsored by Natera, Inc. (industry) · NTRA — their whole pipeline →.
Phase
Not applicable
Status
Not yet recruiting
Study type
Interventional
Design
Randomized · Double · Treatment
Enrollment
1,010estimated
Sites
12
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Oct 2026 | estimated | When the study began enrolling |
| Primary completion | Oct 2034 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Oct 2034 | estimated | The whole study's end, after follow-up |
| First posted | 2026-01-14 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-06-17 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Endometrial Cancer
Intervention
- Device: Signatera Genome ultra-sensitive ctDNA blood test
Primary outcome
what the primary-completion date above is the date OFRecurrence Free Survival (RFS)
measured 3 years from randomization to the first occurrence of disease recurrence or death from any cause, whichever occurs first
Publications
- PMID 25641568 — cited as background
- PMID 15051771 — cited as background
- PMID 16495918 — cited as background
- PMID 35277281 — cited as background
- PMID 33536036 — cited as background
- PMID 34887451 — cited as background
- PMID 36139659 — cited as background
- PMID 31116674 — cited as background
- PMID 35115431 — cited as background
- PMID 17145260 — cited as background
- PMID 39817679 — cited as background
- PMID 35256416 — cited as background
- PMID 35038071 — cited as background
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · NTRA's whole pipeline · Catalyst calendar · Every registered study · What changed